You are here Home
1st Biosimilar Approval

Intas Pharmaceuticals Limited - Gets the 1st Biosimilar Approval for EU

Accofil - filgrastim

Accord Healthcare, the international arm of Intas Pharmaceuticals Ltd, has received marketing authorization for its filgrastim (Brand name Accofil) valid throughout the European Union. The product is manufactured by Intas in its EMA certified plant in India.